We would especially like to hear from:

Neuroscientists seeking to initiate pre-commercial (e.g., ARPA) or early commercial (e.g, SBIR, VC) projects connecting advanced neuroscience to systemic medicine
Investors open to backing early-stage initiatives with first rights to next-stage targeted investments

Other inquiries with insights, ideas, and potential partnerships are also welcome.